Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants
Our study revealed an increased use of combination pulmonary vasodilator therapy, favouring inhaled nitric oxide and sildenafil, yet with considerable practice variation. Further research is needed to determine the optimal combination, sequence, dosing, and disease-specific indications for combination therapy.
Authors
- Jan Hau Lee (ORCID: https://orcid.org/0000-0002-8430-4217)
- Elizabeth C. Ciociola
- James M. Faulkner
- Rachel G. Greenberg (ORCID: https://orcid.org/0000-0003-4156-8543)
- Grishma T. Dixit
- Daniel K. Benjamin (ORCID: https://orcid.org/0000-0002-0764-8585)
- Reese H. Clark (ORCID: https://orcid.org/0000-0002-7363-4640)
- Christoph P. Hornik (ORCID: https://orcid.org/0000-0001-7056-8759)
- Karan R. Kumar (ORCID: https://orcid.org/0000-0001-9196-6350)
- Kristin A. Skinner
- S. Alvarez
- Elijah K. Benjamin
Institutions
- University of North Carolina at Chapel Hill (US)
- Duke University (US)
- Clinical Research Institute (US)
- KK Women's and Children's Hospital (SG)
- Duke-NUS Medical School (SG)
Publication Details
- Journal
- Cardiology in the Young
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1017/s1047951124025976
- Citations
- 1
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Institutes of Health
- National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- Duke Clinical Research Institute
- UCB Pharma